Sign Up Today and Learn More About Cerapedics Stock
Invest in or calculate the value of your shares in Cerapedics or other pre-IPO companies through EquityZen's platform.
Cerapedics Stock (CERA)
CeraPedics is a medical device company that focuses on developing and commercializing novel osteobiologic products.
About Cerapedics Stock
Founded
2001
Headquarters
Westminster, CO, US
Industries
Software, Artificial Intelligence, Data and Analytics
Cerapedics is an orthobiologics company focused on developing its proprietary biomimetic small peptide molecule (P-15) for commercialization in spinal applications. The company was founded in 2001 and is headquartered in Westminster, Colorado.
Cerapedics Press Mentions
Stay in the know about the latest news on Cerapedics
Spine Biologic Market Report 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031
globenewswire • Jan 26, 2026
Cerapedics' PearlMatrix P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator, Now Approved for Expanded Indications for Use
prnewswire • Jan 14, 2026
Orthobiologics Market Research Report, Analysis, Size, Sh...
pharmiweb • Dec 24, 2025
Cerapedics Announces Publication in Spine of 24-Month ASPIRE Study Results of PearlMatrix™ P-15 Peptide Enhanced Bone Graft
biospace • Dec 18, 2025
Cerapedics Announces Publication in Spine of 24-Month ASPIRE Study Results of PearlMatrix™ P-15 Peptide Enhanced Bone Graft Français
newswire • Dec 17, 2025
Cerapedics Management
Leadership team at Cerapedics
Founder
Andrew Tofe
Board of Directors
Chau Khuong
Join now and verify your accreditation status to gain access to:
- Cerapedics Current Valuation
- Cerapedics Stock Price
- Cerapedics Management
- Available deals in Cerapedics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Cerapedics Cap Table and Funding History by Share Class and Liquidity Preferences
- Cerapedics Revenue and Financials
- Cerapedics Highlights
- Cerapedics Business Model
- Cerapedics Risk Factors
- Cerapedics Research Report from SACRA Research
Trading Cerapedics Stock
How to invest in Cerapedics stock?
Accredited investors can buy pre-IPO stock in companies like Cerapedics through EquityZen funds. These investments are made available by existing Cerapedics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Cerapedics stock?
Shareholders can sell their Cerapedics stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
